ABO Pharmaceuticals : Cytogam

Call now to order CYTOGAM direct from ABO Pharmaceuticals!

CytoGamŽ (cytomegalovirus immune globulin intravenous (human)) (CMV-IVIG) is an intravenous immune globulin enriched in antibodies against cytomegalovirus (CMV), and it is indicated for prophylaxis against CMV disease associated with transplantation In transplants of organs from CMV seropositive donors into CMV seronegative recipients, prophylactic CMV-IVIG should be considered in combination with ganciclovir.

CMV is the most common cause of infection occurring after any solid organ transplant, contributing significantly to morbidity and mortality in organ transplant recipients. CMV can cause severe pneumonia and other organ complications related to invasive disease which, if not successfully treated, can lead to organ failure. CMV has also been shown to cause increased bacterial and fungal infections, and has been associated with an increased risk of rejection of the transplanted organ.

Cytogam® is supplied in one single-dose vial form:

NDC Number Quantity of Immunoglobulin Volume Concentration

44206-3101-10 2500 ± 500 mg 50 ml 50 ± 10

CytoGam® is the only IVIG product indicated for the prevention of CMV post transplant.

Cytogam®: Now backed by CSL Behring with over 100 years' expertise in plasma therapy

On December 18, 2006, CSL Behring completed the purchase of Cytogam® from MedImmune, Inc. In doing so, CSL Behring brought a new promise to Cytogam® that includes:

Innovation, quality, and deep insights to the field of organ transplant therapy

Expertise in plasma therapy to bring a safe supply of Cytogam® to transplant healthcare professionals

Partnering with transplant healthcare professionals to ensure that patients can obtain the high-quality products they need

Call now to order CYTOGAM direct from ABO Pharmaceuticals!

For more information about CytogamŽ visit the website at www.cytogam.com

To Place an Order With ABO Pharmaceuticals Call
Toll Free 877-226-2266 or Direct 949-699-2727.